Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0600

+16.5%

3:10 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Howard Williams	7/23/2012 3:52:08 PM
	Read Replies (1) of 13111

Provectus News Companies Offer Updates on Melanoma Therapeutics Monday July 23, 2012 An article appearing in Practical Dermatology July 2012, Vol. 9, No. 7 reports recently released news on melanoma therapeutics, highlighting Phase II clinical results of PV-10. The article is available on the Practical Dermatology website at: Companies Offer Updates on Melanoma Therapeutics Phase II Trial of PV-10 for Melanoma Demonstrates Positive, Consistent Results Monday July 23, 2012 An article appearing in The Dermatologist Vol. 20, Issue 7 entitled "Phase II Trial of PV-10 for Melanoma Demonstrates Positive, Consistent Results" reports on the Phase II results of PV-10 for metastatic melanoma recently presented at the 2nd European Post-Chicago Melanoma Meeting 2012. The article is available on The Dermatologist website at: Phase II Trial of PV-10 for Melanoma Demonstrates Positive, Consistent ResultsProvectus News

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next